Stem cell clinic to ‘vigorously defend’ US FDA lawsuit
The US Department of Justice has filed a lawsuit to stop US Stem Cell Clinic from performing autologous stem cell procedures at the request of the US Food and Drug Administration (FDA).
Archives for May 23, 2018
WuXi Biologics expands manufacturing to Singapore with $60m facility
WuXi Biologics is expanding its manufacturing site network to Singapore with the construction of a $60m facility for clinical and small volume commercial production.
Cellectis submits IND to US FDA for ‘off-the-shelf’ UCART22
Cellectis has submitted an IND for off-the-shelf T-cell candidate UCART22, an allogeneic investigational therapy designed to treat leukemia.